Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer June 2022 22(4):367-373 - Subject
- Language
- ISSN
- 1526-8209